04/19/2024
4:16 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
3:11 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024
6:37 PM | Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
| Form SC 13G | |
03/22/2024
9:24 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 424B5 | |
03/21/2024
4:14 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
11:58 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
8:06 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
8:00 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/29/2023
3:30 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/22/2023
3:02 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2023
3:44 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023
3:45 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
6:35 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2023
3:30 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2023
8:02 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2023
4:25 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2023
12:22 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2023
7:37 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2023
7:30 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2023
7:30 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2023
3:45 PM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2023
7:30 AM | NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
